Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting ...

We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Relay Therapeutics, Inc. (NASDAQ:RLAY) is the ...

Relay Therapeutics upgraded to Outperform: zovegalisib PI3Kα breast cancer catalyst, $596M cash to 2029, Phase 3 mid-2026. Click for more on RLAY stock.

Relay shares had been under pressure since October when initial results from VIKTORIA-1’s wild-type cohort exceeded market ...

According to the company, the committee said that the safety concerns warrant reevaluation of the study design, particularly ...

BTIG analysts have identified their top healthcare picks across various subsectors, highlighting companies with strong near-term catalysts and favorable long-term growth prospects. Here’s a closer ...

The confluence of China’s rapidly rising biotech prowess and US policy decisions that hamper the industry is a cause for ...

Some of the most powerful innovations in teaching don’t come from policy mandates – they come from freedom to play, writes Danny Oppenheimer ...

From Kaouther Ben Hania’s reconstruction of the killing of a five-year-old Gazan girl in The Voice of Hind Rajab to Ira Sachs use of a taped interview in Peter Hujar’s Day, real-life dialogue is being ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that ...

H.C. Wainwright said KRRO-121 adds a second, "independently risk-mitigated asset as a call option." ・Piper Sandler said it ...